Utilisation de traitements radiothérapeutiques plus courts pour le cancer de la prostate https://t.co/IJhlP76lH8
RT @radoncpapers: Hypofractionation for clinically localized prostate cancer. https://t.co/lZAwxD71g9 H/T @NCBI #radonc #PubMed
RT @sandraturner49: ‘Hypofractionation for clinically localized prostate cancer’|Cochrane Library Is prostate cancer #radiationtherapy do…
RT @sandraturner49: ‘Hypofractionation for clinically localized prostate cancer’|Cochrane Library Is prostate cancer #radiationtherapy do…
Hypofractionation for clinically localized prostate cancer. https://t.co/lZAwxD71g9 H/T @NCBI #radonc #PubMed
RT @sandraturner49: ‘Hypofractionation for clinically localized prostate cancer’|Cochrane Library Is prostate cancer #radiationtherapy do…
RT @sandraturner49: ‘Hypofractionation for clinically localized prostate cancer’|Cochrane Library Is prostate cancer #radiationtherapy do…
RT @sandraturner49: ‘Hypofractionation for clinically localized prostate cancer’|Cochrane Library Is prostate cancer #radiationtherapy do…
RT @sandraturner49: Very useful & topical systematic review by @hickmenn and team https://t.co/gwQjNnmYHI
Very useful & topical systematic review by @hickmenn and team
RT @sandraturner49: ‘Hypofractionation for clinically localized prostate cancer’|Cochrane Library Is prostate cancer #radiationtherapy do…
‘Hypofractionation for clinically localized prostate cancer’|Cochrane Library Is prostate cancer #radiationtherapy dose/fractionation lagging behind the evidence like breast cancer still is? #radonc @schin_au @FarshadForoudi https://t.co/0KrdtAX
RT @jeremymillar: Hey, let’s hear it for Brigid Hickey, Melissa James and co-workers for their Cochrane Review on hypofractionation for pro…
RT @jeremymillar: Hey, let’s hear it for Brigid Hickey, Melissa James and co-workers for their Cochrane Review on hypofractionation for pro…
Hey, let’s hear it for Brigid Hickey, Melissa James and co-workers for their Cochrane Review on hypofractionation for prostate cancer, out recently. Who knew?@TargetingCancer @RANZCRcollege @FacRadOncology @DrewMoghanaki https://t.co/LCOerce2pS https://t.c
Using hypofractionation (fewer, larger doses of daily radiation) to treat localized prostate cancer may improve convenience and resource use. A @CochraneLibrary https://t.co/WZgKz3VXM0 suggest that moderate hypofractionation results in similar oncologic ou
RT @Monthy_A: Radioterapia en cáncer de próstata: hipofraccionamiento moderado como nuevo estándar... https://t.co/2HdoDyvdVk
RT @Monthy_A: Radioterapia en cáncer de próstata: hipofraccionamiento moderado como nuevo estándar... https://t.co/2HdoDyvdVk
RT @Monthy_A: Radioterapia en cáncer de próstata: hipofraccionamiento moderado como nuevo estándar... https://t.co/2HdoDyvdVk
RT @Monthy_A: Radioterapia en cáncer de próstata: hipofraccionamiento moderado como nuevo estándar... https://t.co/2HdoDyvdVk
RT @Monthy_A: Radioterapia en cáncer de próstata: hipofraccionamiento moderado como nuevo estándar... https://t.co/2HdoDyvdVk
RT @Monthy_A: Prostate radiotherapy: moderate hypofractionation results in similar oncologic outcomes in terms of disease‐specific, metasta…
RT @roentgen66: Moderate hypofx (up to a fraction size of 3.4 Gy) results in similar oncologic outcomes in terms of disease‐specific, metas…
RT @Monthy_A: Prostate radiotherapy: moderate hypofractionation results in similar oncologic outcomes in terms of disease‐specific, metasta…
RT @Monthy_A: Radioterapia en cáncer de próstata: hipofraccionamiento moderado como nuevo estándar... https://t.co/2HdoDyvdVk
RT @roentgen66: Moderate hypofx (up to a fraction size of 3.4 Gy) results in similar oncologic outcomes in terms of disease‐specific, metas…
Moderate hypofx (up to a fraction size of 3.4 Gy) results in similar oncologic outcomes in terms of disease‐specific, metastasis‐free and overall survival.There appears to be little to no increase in both acute and late toxicity. #pcsm https://t.co/2cAtAX
Prostate radiotherapy: moderate hypofractionation results in similar oncologic outcomes in terms of disease‐specific, metastasis‐free and overall survival #pcsm https://t.co/2HdoDyvdVk
Radioterapia en cáncer de próstata: hipofraccionamiento moderado como nuevo estándar... https://t.co/2HdoDyvdVk